AZN AstraZeneca PLC Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

AZN [NASD]

AstraZeneca PLC

Healthcare | Drug Manufacturers - General | United Kingdom

statements

Index	-	P/E	63.57	EPS (ttm)	0.82	Insider Own	0.50%	Shs Outstand	2.62B	Perf Week	-1.94%
Market Cap	137.22B	Forward P/E	20.45	EPS next Y	2.54	Insider Trans	0.00%	Shs Float	2.60B	Perf Month	-4.01%
Income	2.15B	PEG	3.31	EPS next Q	0.44	Inst Own	17.60%	Short Float	0.20%	Perf Quarter	-8.09%
Sales	25.70B	P/S	5.34	EPS this Y	-39.70%	Inst Trans	0.07%	Short Ratio	1.15	Perf Half Y	1.01%
Book/sh	4.66	P/B	11.16	EPS next Y	28.43%	ROA	3.60%	Target Price	59.73	Perf Year	10.05%
Cash/sh	2.32	P/C	22.44	EPS next 5Y	19.20%	ROE	17.80%	52W Range	36.15 - 64.94	Perf YTD	4.29%
Dividend	1.40	P/FCF	-	EPS past 5Y	1.00%	ROI	8.30%	52W High	-19.93%	Beta	0.56
Dividend %	2.69%	Quick Ratio	0.60	Sales past 5Y	-1.70%	Gross Margin	80.30%	52W Low	43.85%	ATR	1.01
Employees	70600	Current Ratio	0.80	Sales Q/Q	7.80%	Oper. Margin	14.90%	RSI (14)	36.79	Volatility	2.03% 1.59%
Optionable	Yes	Debt/Eq	1.61	EPS Q/Q	481.10%	Profit Margin	8.40%	Rel Volume	1.25	Prev Close	51.96
Shortable	Yes	LT Debt/Eq	1.28	Earnings	Nov 05 BMO	Payout	0.00%	Avg Volume	4.44M	Price	52.00
Recom	1.60	SMA20	-3.34%	SMA50	-5.07%	SMA200	0.62%	Volume	5,545,328	Change	0.08%

Sep-29-20

Initiated

Berenberg

Buy

Nov-22-19

Initiated

SVB Leerink

Outperform

Oct-25-19

Upgrade

Liberum

Hold → Buy

Apr-02-19

Downgrade

UBS

Neutral → Sell

Feb-05-19

Initiated

Exane BNP Paribas

Outperform

Jan-25-19

Upgrade

Shore Capital

Hold → Buy

Dec-11-18

Resumed

Jefferies

Hold

Oct-09-18

Initiated

Guggenheim

Buy

Aug-16-18

Downgrade

Jefferies

Buy → Hold

Mar-19-18

Upgrade

Jefferies

Hold → Buy

Feb-06-18

Reiterated

Leerink Partners

Mkt Perform

$36 → $38

Feb-05-18

Reiterated

Bernstein

Outperform

$40 → $42

Jan-18-18

Reiterated

Leerink Partners

Mkt Perform

$33 → $36

Dec-29-17

Upgrade

JP Morgan

Neutral → Overweight

Oct-16-17

Upgrade

Credit Suisse

Neutral → Outperform

Sep-25-17

Upgrade

Exane BNP Paribas

Neutral → Outperform

Sep-22-17

Upgrade

Bernstein

Mkt Perform → Outperform

Sep-14-17

Downgrade

Liberum

Buy → Hold

Sep-06-17

Upgrade

Natixis Bleichroeder

Neutral → Buy

Aug-09-17

Upgrade

Investec

Hold → Buy

Oct-26-20 02:14AM	Oxford COVID-19 vaccine trials produce robust immune response in elderly - FT Reuters
Oct-25-20 02:33PM	What Are the Differences Between the Leading Coronavirus Vaccine Candidates? Motley Fool
03:03AM	AstraZeneca Gets FDA Nod To Resume US Covid-19 Trial SmarterAnalyst
Oct-23-20 11:55PM	AstraZeneca says its Oxford vaccine deal allows it to add up to 20% of manufacturing costs Reuters
11:09PM	AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same Reuters
06:32PM	AstraZeneca says its Oxford vaccine deal allows it to add up to 20% of manufacturing costs Reuters
03:54PM	WRAPUP 8-AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same Reuters
03:45PM	AstraZeneca Allowed to Resume Covid Vaccine Trial in U.S. TheStreet.com
03:04PM	Doctor on COVID-19 spike: We need to be worried Yahoo Finance Video
02:31PM	WSJ: AstraZeneca can resume COVID-19 vaccine trial in the U.S. MarketWatch
02:23PM	Can Novavax Stock Overcome Growing Vaccine Distrust? InvestorPlace
11:33AM	Coronavirus update: US sets new daily case record; AstraZeneca and J&J to resume trials Yahoo Finance
10:40AM	FARXIGA DAPA-CKD Phase III Trial Reduced Worsening of Kidney Function, Risk of Cardiovascular or Renal Death in Patients With Chronic Kidney Disease Irrespective of Underlying Cause Business Wire
09:44AM	COVID-19 'Pool testing' in schools would give insight on how well masks in schools are doing: Dr. Dara Kass Yahoo Finance Video
06:14AM	Have $1,000? 2 Fantastic Coronavirus Stocks to Buy and Hold for the Next Decade Motley Fool
01:00AM	First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payment From AstraZeneca GlobeNewswire
Oct-22-20 04:51PM	US faces major hurdles for COVID-19 vaccine distribution: Vaccine advisory committee Yahoo Finance
03:34PM	Coronavirus Latest: Thursday, October 22 Yahoo Finance Video
01:59PM	FDA Covid Meeting Shows the Companies Behind the Vaccines Barrons.com
10:37AM	AstraZeneca (AZN), J&J (JNJ) Coronavirus Trials May Resume Soon Zacks
10:19AM	What to expect from the FDA's COVID-19 vaccine meeting today Yahoo Finance Video
09:00AM	AstraZeneca Announces Winners and Recognizes Unsung Heroes of Oncology in 2020 Cancer Community (C2) Awards Business Wire
06:05AM	Study finds AstraZeneca's COVID-19 vaccine follows genetic instructions Reuters
Oct-21-20 04:34PM	Coronavirus Latest: Wednesday, October 21 Yahoo Finance Video
04:12PM	Brazil Healthcare Regulator Says Patient in AstraZeneca Coronavirus Vaccine Trial Dies Motley Fool
04:00PM	Participant In AstraZeneca, Oxford University COVID-19 Vaccine Trial Dies Benzinga
03:50PM	Sorrento Therapeutics Is a Vaccine Movie That Investors Have Already Seen InvestorPlace
02:16PM	Participant in AstraZeneca Vaccine Trial Dies Barrons.com
01:58PM	AstraZeneca vaccine trial would have stopped if deceased volunteer part of active arm - source Reuters
01:33PM	Coronavirus update: Deaths on the rise as new COVID-19 wave starts to swamp US, Europe Yahoo Finance
12:14PM	2 Late-Stage Coronavirus Vaccine Candidates in Limbo Motley Fool
10:46AM	AstraZeneca's (AZN) Tagrisso sNDA Receives Priority Review Zacks
09:30AM	The Zacks Analyst Blog Highlights: NVIDIA, Salesforce, AstraZeneca, JPMorgan and Chevron Zacks
04:34AM	AstraZenecas Covid-19 Trial Slated To Resume This Week Report SmarterAnalyst
12:35AM	AstraZeneca Could Resume US COVID-19 Vaccine Trial This Week As FDA Review Complete: Report Benzinga
Oct-20-20 06:41PM	U.S. Trial With AstraZeneca's Coronavirus Vaccine Expected to Resume Soon Motley Fool
04:27PM	U.S. COVID-19 cases climbing to new peak amid fall surge Yahoo Finance Video
02:58PM	Top Analyst Reports for NVIDIA, salesforce & AstraZeneca Zacks
02:46PM	Doctor of COVID-19 vaccine: Its unlikely well see the data before the election Yahoo Finance Video
12:47PM	Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources Reuters
12:45PM	Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources Reuters
10:52AM	AstraZeneca (AZN) Gets CHMP Nod for Forxiga in Heart Failure Zacks
10:49AM	UK launches world's first human challenge trial for COVID-19 with hVivo Yahoo Finance Video
10:12AM	Moderna's COVID-19 vaccine timeline Yahoo Finance Video
08:01AM	TAGRISSO Granted Priority Review in the US for the Adjuvant Treatment of Patients With Early-stage EGFR-mutated Lung Cancer Business Wire
07:12AM	What's the Outlook for AstraZeneca Stock? Motley Fool
Oct-19-20 05:45PM	Astrazeneca (AZN) Stock Moves -1.11%: What You Should Know Zacks
09:09AM	AstraZeneca Gets EU Recommendations For Heart Failure, Lung Treatments SmarterAnalyst
06:54AM	AstraZeneca Gets EU Committee Recommendation For Approval Of Heart Failure, Lung Cancer Treatments Benzinga
02:23AM	AstraZeneca wins two approval recommendations from EU agency Reuters
Oct-18-20 07:01PM	Vaccine Doubters Could Hamper Global Effort to Beat Coronavirus Bloomberg
Oct-17-20 08:09AM	Better Coronavirus Stock: AstraZeneca or Johnson & Johnson Motley Fool
07:40AM	What You Need to Know at This Stage of the Coronavirus Vaccine Race Motley Fool
07:07AM	Better Coronavirus Stock: AstraZeneca or Moderna? Motley Fool
Oct-16-20 03:24PM	Misinformation is the 'biggest concern' leading up to election: CrowdStrike President Yahoo Finance Video
01:53PM	Can Cytonics Pivot Successfully to Covid-19 Therapeutics? InvestorPlace
01:26PM	EXPLAINER-When will COVID-19 vaccines be generally available in the United States? Reuters
09:57AM	Coronavirus update: Pfizer seeks vaccine authorization in November; Medicare cuts delayed COVID-19 testing payments Yahoo Finance
08:23AM	Pharma Stock Roundup: J&J's Q3 Earnings, Pause on Coronavirus Studies & Other Updates Zacks
07:58AM	Biden Town Hall: 4 Key Investing Takeaways InvestorPlace
04:59AM	Swiss to buy 5.3 mln doses of AstraZeneca COVID-19 vaccine Reuters
Oct-15-20 11:59AM	Coronavirus update: CDC eyes small groups as US cases spike; Sanofi announces pre-clinical vaccine data Yahoo Finance
09:41AM	Coronavirus second wave looms: 'Hope for the best but prepare for the worst' Yahoo Finance
Oct-14-20 04:44PM	The medical community has learnt a lot and are better prepared for the next phase: doctor Yahoo Finance Video
04:29PM	Coronavirus Latest: Wednesday, October 14 Yahoo Finance Video
04:22PM	Will Covid-19 Vaccine Race Leaders Pfizer, BioNTech Post Initial Phase 3 Data This Week? Investor's Business Daily
12:22PM	Kids may not be recommended for COVID-19 vaccination initially, U.S. CDC says Reuters
11:45AM	U.S. puts Eli Lilly's COVID-19 antibody trial on hold due to safety concerns Yahoo Finance Video
11:14AM	How to Invest In Covid-19 Vaccines and Treatments When Trials Keep Getting Paused Barrons.com
09:31AM	Stock Market News for Oct 14, 2020 Zacks
09:18AM	Eli Lilly (LLY) Selling Off After Safety Disclosures Investopedia
08:38AM	There are seven coronavirus vaccine candidates being tested in the U.S. heres where they stand MarketWatch
08:17AM	Lilly's Coronavirus Antibody Study Paused on Safety Concerns Zacks
08:00AM	Britain's spies defending COVID-19 vaccine work, MI5 chief says Reuters
Oct-13-20 04:24PM	Eli Lilly Pauses Covid-19 Treatment Clinical Trials Over Safety Concerns Investor's Business Daily
04:18PM	Johnson & Johnson Pauses Covid-19 Vaccine Tests; Raises Earnings Guidance Investor's Business Daily
03:56PM	Johnson & Johnson, Eli Lilly both pause COVID-19 trials amid safety concerns Yahoo Finance Video
03:30PM	Coronavirus Latest: Tuesday, October 13 Yahoo Finance Video
03:20PM	A study testing Lilly's antibody treatment and remdesivir is paused MarketWatch
12:10PM	Canada to review Moderna's COVID-19 vaccine candidate in real time Reuters
11:35AM	Coronavirus update: J&J vaccine trial hits pause as US doubles down on antibody therapies Yahoo Finance
11:20AM	J&J Investors Are Fixated on Vaccines Like Everyone Else Bloomberg
10:37AM	The pause in Johnson & Johnsons COVID-19 vaccine trial justifies why Big Pharma isnt eager to rush to market MarketWatch
09:12AM	2 Great Stocks to Buy With Just $100 Motley Fool
08:45AM	Morning Bell With Jim Cramer: Buy Pepsi Stock TheStreet.com
08:12AM	Johnson & Johnson Pauses Covid-19 Vaccine Trial Due to Unexplained Illness Barrons.com
Oct-12-20 11:24PM	Report: Johnson & Johnson Coronavirus Vaccine Study Paused Due To Participant's Unexplained Illness Motley Fool
07:12PM	Asian Stocks Fall Over Potential COVID-19 Vaccine Hiccup Investing.com
05:49PM	Columbia University virologist on why Trump events are an "incredible risk" for spreading COVID-19 Yahoo Finance Video
05:45PM	Astrazeneca (AZN) Gains But Lags Market: What You Should Know Zacks
04:17PM	AstraZeneca Covid-19 Treatment Pact With U.S. Boosts AZN Stock Investor's Business Daily
04:15PM	BioNTech, Pfizer Sign Covid-19 Vaccine Deal With New Zealand; Seek Drug OK This Year Investor's Business Daily
03:55PM	Little bit early to say Moderna is the savior in the COVID-19 vaccine race: Analyst Yahoo Finance Video
02:44PM	Emergency Physician on AstraZeneca COVID-19 treatment: We should be expecting something that is available for everybody Yahoo Finance Video
01:53PM	Johns Hopkins Doctor: It is critical we dont let political pressure overcome science Yahoo Finance Video
01:02PM	U.K. Outlines New Local Lockdown System Barrons.com
11:38AM	Stocks on the move: AstraZeneca moves into late-stage trials, Carnival cancels cruises from Port Canaveral, Miami Yahoo Finance Video
11:31AM	AstraZeneca's Coronavirus Antibody Therapy to Enter Late Stage Zacks
10:23AM	ROCE Insights For AstraZeneca Benzinga
08:31AM	The next big market mover, according to Wall St. Yahoo Finance

AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience